Searched for
ACN HEALTHCARE
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- PCOS now PMOS: Health condition that affects every eighth woman renamed after 14 years of misunderstandingPolycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its systemic impact bey...
- PCOS renamed: Experts propose new name for Polycystic Ovary Syndrome for better care and awareness—here's what you need to knowGlobal health experts are proposing to rename Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This cha...
- Amazon launches healthcare AI assistant on its website, appThe artificial intelligence assistant can explain results, connect patients with providers and answer questions about medications and sym...
- True North to invest Rs 150 cr in ACN Healthcare, to fund growth, expansion of serviceTrue North Private Equity's Credit Opportunities Fund I is investing Rs 150 crore in ACN Healthcare RCM, a leading Revenue Cycle Management...
- Sara Tendulkar said no to Bollywood but chose this more meaningful career instead. ‘Acting is not for me’Sara Tendulkar, daughter of cricket icon Sachin Tendulkar, has clarified that she has no interest in pursuing a Bollywood career. In an int...
- Glenmark, Cosmo get MHRA nod for acne treatment medicationGlenmark Pharmaceuticals and Cosmo Pharmaceuticals have received MHRA approval to market Winlevi, a topical acne treatment for patients age...
- Dermatology platform Cureskin raises $20 million in funding led by HealthQuadThe company will utilise the newly-raised funds to enhance its AI capabilities further and broaden its range of solution offerings, it said...
- Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US, CanadaSun Pharma, North America CEO Abhay Gandhi said the expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Im...
- Covid-19 has triggered 'much needed govt focus on healthcare': Reckitt Benckiser global chiefRB had said in July that its Dettol brand became the largest-selling soap in India for the first time as consumers spent extensively on the...
- Lupin gets USFDA approval for generic contraceptive drugThe company has received final approval from the USFDA to market its product which is a generic version of Bayer HealthCare Pharmaceutical ...
- Cadila Healthcare rises 2% on USFDA approval to antibiotic drugThis medication is also used for prophylaxis of malaria.
- Zydus gets final nod from USFDA for anti-bacterial drugZydus Cadila is a global pharmaceutical company that develops, manufactures and markets a broad range of healthcare therapies. The group em...
- About 18 per cent women in India affected by PCOS: StudyPolycystic Ovarian Syndrome is a prevalent endocrine disorder in women and the leading cause of infertility nowdays.
- Vyome Biosciences closes $8 million funding roundProceeds from the Series B round of funding will be used to drive the completion of critical milestones of US Food and Drug Administration ...
- Ranbaxy launches anti-acne drug in the US marketAccording to an analyst, the launch of Absorica would greatly benefit Ranbaxy as there are only 2-3 players currently selling the product i...
- Ozone Ayurvedics launches anti acne productOzone Ayurvedics, a producer of herbal health and beauty care products, on Tuesday announced the launch an anti-acne product, targeting a t...
- Wockhardt in licensing pact with UK firm for acne drugWockhardt Ltd has signed an in-licensing agreement with Crawford Healthcare, UK to market Zindaclin, a patented topical application for acn...
- Ranbaxy buys rights for 13 dermatology productsRanbaxy Laboratories on Monday said it has acquired the US marketing rights for 13 dermatology products from Bristol-Myers Squibb Company (...
- Cadila to hive off health goods bizAhmedabad-Based Cadila Healthcare, the Zydus Group flagship, will soon spin off its consumer healthcare division into a separate company.
Load More
